Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

AGM Presentation

November 12, 2015August 16, 2022 Alterity Therapeutics

2015_11_13 Prana AGM Presentation 2

2015

Post navigation

Prana AGM Webcast Details

Prana Maintains NASDAQ Listing

Related Posts

Prana Biotechnology 2018 AGM Presentation

November 16, 2018August 16, 2022

Alterity presents clinical data on PBT434 at the 2019 MDS Congress

September 25, 2019August 16, 2022

Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom

April 27, 2022August 16, 2022

Recent Posts

Chairman’s Address 2023 Annual General Meeting
AGM 2023 Presentation
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
Alterity Therapeutics Raises $4.8M AUD in Placement
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065